Ensuring Access to Lower-Cost Medicines for Seniors Act
Summary
Ensuring Access to Lower-Cost Medicines for Seniors Act This bill requires prescription drug plans under the Medicare prescription drug benefit to include generic drugs and biosimilars on their formularies. Specifically, the bill requires plans that use formularies to include generic drugs and biosimilars on the formularies and without any requirements (e.g., prior authorization requirements) that are more restrictive as compared to those for brand-name drugs and biologics. Plans that use cost-sharing tiers must also have specific tiers for generic drugs and biosimilars, in accordance with certain limitations.
Bill status
in committee
1 of 4 stages cleared
Introduction
Apr 2026
Committee Review
Floor Vote
President
Introduced Apr 16, 2026
Last action Apr 16, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Apr 16, 2026
Committee
Read twice and referred to the Committee on Finance.
upper
Apr 16, 2026
Introduced
Introduced in Senate
upper
1 primary · 2 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
James Lankford
RRepublican
Co
Margaret Wood Hassan
DDemocratic
Co
Michael F. Bennet
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about S 4323
Scope: US
Hi! I can help you understand S 4323. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline